SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), focused on the development of DNA vaccines for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers, announced today that Dr. Avtar Dhillon, president and CEO, will present a corporate overview at the Thomas Weisel Partners Healthcare Conference in Boston, MA, on Thursday, September 6, 2007 at 3:50 p.m. EDT.
